Salmonella In Kratom, Like Use Of The Herb, Exceeds FDA Expectations

Commissioner Scott Gottlieb says prior to investigating a "large outbreak of salmonellosis," FDA determined there are no proven medical uses for kratom and that it is inherently addictive and can cause harm. "The subsequent findings of this investigation only strengthen that public health recommendation. … Now, in addition to those risks, we can conclude that there may be a high proportion of kratom and kratom-containing products contaminated with salmonella," he says.

The link between kratom and salmonella is more widespread than FDA previously suspected, prompting the agency to warn that consumers using the botanical in dietary supplements or other products "may be placing themselves at a significant risk of being exposed to" the contaminant.

When FDA on July 2 announced it has ended its investigation of a "large outbreak of salmonellosis" linked to kratom, it also noted that the herb extracted from a plant in the coffee family is not

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from International

More from Geography

OTCs Are ‘Beacon Of Hope’ For Austrian Pharmacy

 
• By 

Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”

Melatonin And Buccal Acyclovir On German Switch Committee Agenda

 
• By 

An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By 

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.